The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -52,235 |
| Goodwill impairment | 102,560 |
| Impairment of long-lived assets | 0 |
| Provision for credit losses | 912 |
| Deferred tax expense (benefit) | 3,195 |
| Depreciation and amortization | 29,768 |
| Amortization of developed technology and backlog | 17,520 |
| Amortization of debt discount and issuance costs | 5,216 |
| Gain on extinguishment of debt, net | 14,207 |
| Gain on debt refinancing | 0 |
| Equity-based compensation | 15,571 |
| Change in fair value of contingent consideration | 177 |
| Warranty provision | 17,273 |
| Inventory valuation reserves | 3,515 |
| Inventory reserve | 29,516 |
| Other non-cash | 2,032 |
| Accounts receivable | -31,008 |
| Inventories | -52,852 |
| Income tax receivables | 6,849 |
| Prepaid expenses and other | 25,844 |
| Accounts payable | -35,868 |
| Accrued expenses and other | -54,136 |
| Income tax payable | -540 |
| Lease liabilities | 2,202 |
| Deferred revenue | 489 |
| Other operating assets and liabilities | 18,278 |
| Net cash provided by operating activities | 101,785 |
| Purchase of property, plant and equipment | 21,972 |
| Acquisition, net of cash acquired | 164,916 |
| Retirement/disposal of property, plant and equipment | 0 |
| Cash payments for the acquisition of right-of-use assets | 0 |
| Investment in securities | 1,000 |
| Sale of equity investment | 0 |
| Net cash used in investing activities | -187,888 |
| Proceeds from issuance of other debt | 151,151 |
| Proceeds from issuance of convertible notes | 345,000 |
| Premium paid on capped call | 35,087 |
| Fees paid on issuance of convertible notes | 10,434 |
| Repayments of other debt | 174,392 |
| Repayments of term loan facility | 233,875 |
| Repayments of convertible notes | 78,363 |
| Contingent consideration payments | 1,204 |
| Other financing | -849 |
| Net cash used in financing activities | -38,053 |
| Effect of exchange rate changes on cash and cash equivalent balances | 5,999 |
| Net change in cash and cash equivalents | -118,157 |
| Cash and cash equivalents and restricted cash, beginning of period | 364,141 |
| Cash and cash equivalents and restricted cash, end of period | 245,984 |
Array Technologies, Inc. (ARRY)
Array Technologies, Inc. (ARRY)